London Genetics alters management
The management team at London Genetics Ltd has undergone some changes. Dr. Barrie Ward, formerly with GlaxoSmith Kline, will now act as Chairman of the British pharmacogenetics specialist. Dominique Kleyn, who led business development and tech transfer at Imperial College London, has been appointed as the firm’s CEO. And hypertension expert Dr. Mark Caulfield has been named the company’s new Clinical Director.